Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influenza Vaccine Immunogenicity in Extremely Premature Infants

NCT00455169 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT00455169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Lead sponsor
University of Rochester
Phase
Observational
Overall status
Completed
Start date
October 31, 2007
Completion date
May 31, 2008
Enrollment
66 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

infant, premature, influenza